One of the most essential qualifications performed within sterile pharmaceutical manufacturing facilities is the execution of smoke studies (airflow visualization studies). These prove by visual verification that the airflow produced protects the sterile products during manufacturing, filling and during any aseptic activity.
Due to the publication of the EU GMP Annex 1 (2022), there have been many updates to the expectations of the regulatory authorities regarding these smoke studies. Inspectors now require that pharmaceutical companies perform their smoke studies and demonstrate that the airflow will consistently remain effective over the course of routine operations (while a user is operating equipment).
In my experience, the HVAC performance of the facility itself is rarely the sole reason for a failure. More commonly, failure results from the lack of a plan, the study being executed in unrealistic conditions or due to a lack of documentation. Smoke studies should be designed to answer a simple question; "Does the airflow consistently protect the product throughout the entire manufacturing process?".
Each smoke study is evaluated for:
A Smoke Study confirms:
A dynamic smoke study will include:
To ensure that the current day's operations are consistent with validated airflow conditions, it is recommended that facilities periodically review historical smoke studies.
Recommended Best Practices:
Smoke studies serve a much greater purpose than just meeting regulatory requirements, they visually demonstrate how cleanroom airflow protects sterile product through manufacture. While many organizations seem to place more emphasis on producing acceptable videos other than actually identifying contamination risks before they impact product quality are experienced pharmaceutical professionals.
I have found that the more successful pharmaceutical manufacturers tend to use smoke studies more as a continuous improvement tool and less as a qualification exercise. By performing realistic, risk-based studies that are well-documented and scientifically validated, manufacturers can further develop their contamination control strategy; improve the reliability of their aseptic process and confidently provide evidence of regulatory compliance when needing to during a regulatory inspection.
https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en
2. FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice
https://www.fda.gov/media/71026/download
3. WHO Good Manufacturing Practices for Sterile Pharmaceutical Products
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/gmp
Due to the publication of the EU GMP Annex 1 (2022), there have been many updates to the expectations of the regulatory authorities regarding these smoke studies. Inspectors now require that pharmaceutical companies perform their smoke studies and demonstrate that the airflow will consistently remain effective over the course of routine operations (while a user is operating equipment).
In my experience, the HVAC performance of the facility itself is rarely the sole reason for a failure. More commonly, failure results from the lack of a plan, the study being executed in unrealistic conditions or due to a lack of documentation. Smoke studies should be designed to answer a simple question; "Does the airflow consistently protect the product throughout the entire manufacturing process?".
What is Smoke Study?
Smoke studies are demonstrations of airflow that visually illustrate the path taken by air and its effect on product sterility. They are conducted using a non-toxic or otherwise harmless smoke generator in a controlled environment to assess the air flow characteristics in a pharmaceutical cleanroom.Each smoke study is evaluated for:
- The presence of unidirectional airflow.
- How quickly or slowly air is recovered once it is removed from critical areas or processes.
- Airflow velocity (velocity of air moving past an object).
- Obstructions to the flow of air within critical areas.
- Presence or absence of turbulence in the vicinity of critical areas.
- Protection of exposed sterile products from contamination due to airflow.
Importance of a Smoke Study
The air movement through a facility is a critical control measure for preventing contamination while manufacturing sterile products.A Smoke Study confirms:
- HEPA filtered air reaches all critical areas in a timely manner.
- First air at exposed product locations is being maintained continuously.
- The actions of personnel do not disturb the airflow needed to protect the exposed product.
- The locations of equipment do not create turbulence.
- Return air systems effectively remove contamination from the facility.
Regulatory Expectations
There are numerous international regulations that require creating airflow visualization studies. Regulatory authorities generally expect that the results of airflow visualization studies use smoke studies to demonstrate the following types of information:- Dynamic operation
- Representation of the actual processes being used
- Worst case scenarios
- Adequate documentation via video
- Scientific analysis
- Risk based assessment
Common Smoke Study Mistakes
Organizations use the analysis of the most frequent mistakes of common smoke studies to improve study quality and regulatory compliance.1. Performing Studies Only Under Static Conditions
Conducting a smoke study in an empty room without an operator or equipment moving. Nothing about manufacturing operates in a static condition.A dynamic smoke study will include:
- Equipment moving
- Operators moving
- Materials transfer
- Doors opening (if applicable)
- Routine intervention
2. Ignoring Worst-Case Conditions
Only testing smoke studies under normal operational conditions. Testing smoke studies under worst-case conditions should occur and can include:- Maximum number of operators
- The longest equipment configuration
- More than one operator/helper doing a routine intervention at the same time
- The largest package product configuration
- Maximum amount of material in the equipment
3. Incorrect Smoke Generator Placement
Introducing smoke from a location that does not match where real contamination may happen, thereby producing misleading airflow patterns. The smoke generator should reflect real-life sources of contamination found in the following areas:- Your hands as an operator
- Equipment surface areas
- Location of transfer points for items or material
- Location of open containers
- Critical processing area
4. Excessive Smoke Generation
Producing excessive amounts of smoke will not yield more accurate results. Heavy smoke clouds can have several negative effects on an experiment:- They may disrupt airflow, thereby obscuring any visualization available
- They may create artificial turbulence or velocity misrepresentation
- They can distort the airflow
5. Poor Video Documentation
Regulatory agencies want records to be of good quality. The most common issues with documenting via video are:- Bad camera position
- Insufficient lighting
- Recording was not completed
- Did not include a stamp with time
- Short length of recording
6. Failing to Evaluate Operator Interventions
Operators are the biggest contributor to contamination in aseptic processing. Smoke studies should include all interventions to the aseptic process including:- Putting things away
- Loading parts
- Moving their gloves
- Disposing of goods
- Adding stoppers
7. Ignoring Airflow Obstructions
Changes in equipment can also change the airflow. Common airflow obstructions include:- Large filling machines
- Cameras
- Sensors
- Product containers
- Temporary tools
8. Inadequate Protocol Design
Poorly designed protocols frequently yield incomplete studies. Properly designed protocols should provide:- Study goal definition
- Testing locations
- Smoke generator specifications
- Acceptance criteria
- Intervention scenarios
- Data collection methods
- Individual responsibilities
9. Incorrect Interpretation of Airflow
Not all visible turbulence is necessarily unacceptable airflow. Investigators should distinguish between:- Localized turbulence that is acceptable
- Recovery of airflows
- Interruption of first air
- Risk of product exposure to contamination
10. Treating Smoke Studies as a One-Time Activity
Some organizations only perform smoke studies when qualifying a facility. As airflow is modified due to the following conditions, airflow should be retested each time.- Modifications to equipment
- HVAC system changes
- Renovation or modifications to facilities
- Modification to processes
- Major maintenance
- Introduction of a new product
Root Causes Behind Smoke Study Deficiencies
System-wide problems often result in multiple instances of inadequate or faulty smoke study results. Traditional system-wide issues can stem from the following:- Inadequate contamination control program
- Insufficiently trained personnel in smoke testing procedures
- Weak risk assessments for planned smoke tests
- Poorly prepared smoke test protocols
- Limited knowledge of airflow principals
- Inadequate planning
- Lack of resources
Solutions for Effective Smoke Studies
There are many proven ways that organizations can enhance their study quality through best practices.1. Develop a Risk-Based Protocol
Protocols should be developed with the use of Quality Risk Management principles. Risk-based testing provides stronger scientific justification by focusing on:- Critical processing locations
- High-risk activities
- Worst-case scenarios
- Product exposure points
2. Simulate Regular Manufacturing Operations
Smoke studies should be as similar as possible to normal production due to:- Normal batch processing
- Movement of equipment
- Different worker activities
- Material transfer
- Cleaning activity
3. Train Personnel Thoroughly
Administration of a smoke study requires personnel to know:- Airflow
- Contamination control
- Placement of camera
- Operation of smoke generator
- Regulatory expectations
4. Improve Video Quality
Use:- Multiple cameras
- High definition recording
- Adequate lighting
- Continuous recording
- Visible timestamps
5. Conduct a Cross-Functional Review of Smoke Studies
Interpretations of a smoke study should include input from:- Quality Assurance
- Validation
- Production
- Engineering
- Microbiology
Role of Smoke Studies in Contamination Control Strategy
Contamination control strategies will include smoke studies as a part of their compliance with EU GMP Annex 1. They will provide information regarding:- Airflow design
- People working in the areas
- Equipment arrangement
- Aseptic process methods
- Improvements in processes
Preparing for Regulatory Inspections
The requirements for the FDA and European inspections start with the submission of smoke study protocols. Other requirements may include raw video, study report, investigation records, CAPA documentation and risk assessments.To ensure that the current day's operations are consistent with validated airflow conditions, it is recommended that facilities periodically review historical smoke studies.
Best Practices for Successful Smoke Studies
General good practices for successful smoke studies are typically followed by an organization that has a mature contamination control program.Recommended Best Practices:
- Conduct studies under dynamic conditions.
- Challenge the worst potential interventions.
- Use scientifically justified smoke generation techniques.
- Record high-quality video from multiple angles.
- Evaluate first air protection continuously.
- Review airflow as it relates to changes made to equipment or processes.
- Integrate smoke studies into your contamination control strategy.
- Train personnel on airflow visualization techniques regularly.
- Have a complete record of documentation.
- Periodically trend findings and implement CAPA as needed.
I have found that the more successful pharmaceutical manufacturers tend to use smoke studies more as a continuous improvement tool and less as a qualification exercise. By performing realistic, risk-based studies that are well-documented and scientifically validated, manufacturers can further develop their contamination control strategy; improve the reliability of their aseptic process and confidently provide evidence of regulatory compliance when needing to during a regulatory inspection.
Regulatory References
1. EU GMP Guidelines Volume 4, Annex 1: Manufacture of Sterile Medicinal Products (2022)https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en
2. FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice
https://www.fda.gov/media/71026/download
3. WHO Good Manufacturing Practices for Sterile Pharmaceutical Products
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/gmp

No comments:
Post a Comment
Please don't spam. Comments having links would not be published.